首页> 外文期刊>Indian journal of clinical biochemistry: IJCB >The Assessment of Oxidative Stress on Patients with Chronic Renal Failure at Different Stages and on Dialysis Patients Receiving Different Hypertensive Treatment
【24h】

The Assessment of Oxidative Stress on Patients with Chronic Renal Failure at Different Stages and on Dialysis Patients Receiving Different Hypertensive Treatment

机译:慢性肾功能衰竭患者不同阶段及接受不同高血压治疗的透析患者的氧化应激评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of this study is to evaluate the oxidative stress in predialysis, hemodialysis (HD) and peritoneal dialysis patients and to test the effects of antihypertensive drugs and volume control on oxidative stress parameters. The study was composed of five groups as follows: control group (n = 30), predialysis group (n = 30), peritoneal dialysis group (n = 30), hemodialysis group, (normotensive with strict volume control, n = 30), hemodialysis group (normotensive with medication, n = 30). Plasma malondialdehyde (MDA), erythrocyte superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GSHPx) and routine biochemical parameters were studied in all patients. Hemodialysis patients with strict volume control (HD_(VC)) had lower levels of MDA than other patient groups (p < 0.001), and CAT, SOD values had highest level other patient groups (p< 0.001). The treatment of hypertension with strict volume control in chronic renal failure patients causes less damage to the antioxidant capacity.
机译:这项研究的目的是评估透析前,血液透析(HD)和腹膜透析患者的氧化应激,并测试降压药和音量控制对氧化应激参数的影响。该研究由五组组成,分别为:对照组(n = 30),透析前组(n = 30),腹膜透析组(n = 30),血液透析组(血压正常且严格控制体积,n = 30),血液透析组(使用药物降血压,n = 30)。在所有患者中研究血浆丙二醛(MDA),红细胞超氧化物歧化酶(SOD),过氧化氢酶(CAT),谷胱甘肽过氧化物酶(GSHPx)和常规生化参数。严格控制血液透析(HD_(VC))的血液透析患者的MDA水平低于其他患者组(p <0.001),而CAT,SOD值最高的其他患者组(p <0.001)。在慢性肾功能衰竭患者中,通过严格控制容量来治疗高血压对抗氧化能力的损害较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号